# HAGH

## Overview
The HAGH gene encodes the enzyme hydroxyacylglutathione hydrolase, also known as glyoxalase II, which is a crucial component of the glyoxalase system involved in cellular detoxification processes. This enzyme is categorized as a hydrolase and plays a significant role in the conversion of S-D-lactoylglutathione to reduced glutathione and D-lactic acid, thereby mitigating oxidative stress by detoxifying methylglyoxal, a cytotoxic byproduct of glycolysis (Farrera2022The). Structurally, glyoxalase II is characterized by a binuclear metal site, primarily involving zinc ions, which are essential for its catalytic activity (Scirè2022Glyoxalase; Cameron1999Crystal). The enzyme exists in both mitochondrial and cytosolic forms, with the mitochondrial variant being slightly larger due to an additional targeting sequence (Scirè2022Glyoxalase). The proper functioning of HAGH is vital for maintaining cellular homeostasis and protecting against oxidative damage, with implications for various diseases, including cancer, diabetes, and neurodegenerative disorders (Farrera2022The; Ahmad2020CDH6).

## Structure
The human gene HAGH encodes the enzyme hydroxyacylglutathione hydrolase, also known as glyoxalase II, which plays a role in detoxifying methylglyoxal. The protein structure consists of two main domains: an N-terminal domain and a C-terminal domain. The N-terminal domain, comprising residues 1-173, features a four-layered β sandwich topology with two mixed β sheets flanked by α helices, similar to metallo-β-lactamases (Scirè2022Glyoxalase; Cameron1999Crystal). The C-terminal domain, spanning residues 174-260, is predominantly α-helical and interacts tightly with the N-terminal domain (Cameron1999Crystal).

The active site of glyoxalase II contains a binuclear metal site, primarily involving zinc ions, which are crucial for its catalytic function (Scirè2022Glyoxalase; Cameron1999Crystal). The enzyme is a monomer with a molecular weight of approximately 29 kDa (Cameron1999Crystal). Glyoxalase II can utilize other metal ions such as iron and manganese, and its activity is sensitive to salt and pH levels (Pettinati2016The; Scirè2022Glyoxalase).

The gene produces two transcripts, one encoding a mitochondrial form and another a cytosolic form, with the mitochondrial form being slightly larger due to an additional targeting sequence (Scirè2022Glyoxalase). The enzyme is involved in post-translational modifications, such as S-glutathionylation, which may play roles in cell signaling and cancer biology (Scirè2022Glyoxalase).

## Function
The HAGH gene encodes the enzyme hydroxyacylglutathione hydrolase, which plays a critical role in the glyoxalase system, a cellular mechanism responsible for detoxifying methylglyoxal, a cytotoxic byproduct of glycolysis. This enzyme catalyzes the conversion of S-D-lactoylglutathione to reduced glutathione and D-lactic acid, a rate-limiting step in the glyoxalase cycle, thereby maintaining cellular redox balance and protecting cells from oxidative stress (Farrera2022The). HAGH is active in the cytoplasm, where it contributes to the detoxification of reactive dicarbonyls, preventing damage to lipids, proteins, and DNA, and mitigating stress responses (Farrera2022The).

In healthy human cells, the glyoxalase system, including HAGH, is essential for controlling oxidative stress, which is implicated in various disease conditions. Elevated levels of methylglyoxal can lead to the formation of reactive oxygen species (ROS), and the glyoxalase system helps to prevent this by converting methylglyoxal into non-toxic lactic acid (Ahmad2020CDH6). This detoxification process is crucial for maintaining cellular homeostasis and preventing metabolic diseases (Farrera2022The).

## Clinical Significance
Mutations or alterations in the expression of the HAGH gene, which encodes the enzyme hydroxyacylglutathione hydrolase, can have significant clinical implications. This enzyme plays a crucial role in the detoxification of methylglyoxal, a cytotoxic byproduct of glycolysis. Disruptions in HAGH function can lead to increased oxidative stress and impaired cellular metabolism, contributing to the pathogenesis of several diseases.

In cancer, altered HAGH expression may affect tumor progression and response to therapy by modulating oxidative stress levels within cells. The imbalance in detoxification processes can promote a cellular environment conducive to cancer development and progression. Similarly, in diabetes, impaired HAGH activity can exacerbate oxidative stress, which is a known factor in the development of diabetic complications. The accumulation of methylglyoxal and other reactive metabolites can damage cellular components, leading to insulin resistance and beta-cell dysfunction.

Neurodegenerative diseases may also be linked to HAGH dysfunction. Increased oxidative stress and impaired detoxification can contribute to neuronal damage and the progression of conditions such as Alzheimer's and Parkinson's disease. The precise mechanisms by which HAGH alterations influence these diseases are still under investigation, but the enzyme's role in maintaining cellular redox balance is critical.


## References


[1. (Cameron1999Crystal) Alexander D Cameron, Marianne Ridderström, Birgit Olin, and Bengt Mannervik. Crystal structure of human glyoxalase ii and its complex with a glutathione thiolester substrate analogue. Structure, 7(9):1067–1078, September 1999. URL: http://dx.doi.org/10.1016/s0969-2126(99)80174-9, doi:10.1016/s0969-2126(99)80174-9. This article has 161 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/s0969-2126(99)80174-9)

[2. (Pettinati2016The) Ilaria Pettinati, Jürgen Brem, Sook Y. Lee, Peter J. McHugh, and Christopher J. Schofield. The chemical biology of human metallo-β-lactamase fold proteins. Trends in Biochemical Sciences, 41(4):338–355, April 2016. URL: http://dx.doi.org/10.1016/j.tibs.2015.12.007, doi:10.1016/j.tibs.2015.12.007. This article has 88 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.tibs.2015.12.007)

[3. (Farrera2022The) Dominique O. Farrera and James J. Galligan. The human glyoxalase gene family in health and disease. Chemical Research in Toxicology, 35(10):1766–1776, September 2022. URL: http://dx.doi.org/10.1021/acs.chemrestox.2c00182, doi:10.1021/acs.chemrestox.2c00182. This article has 14 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1021/acs.chemrestox.2c00182)

[4. (Scirè2022Glyoxalase) Andrea Scirè, Laura Cianfruglia, Cristina Minnelli, Brenda Romaldi, Emiliano Laudadio, Roberta Galeazzi, Cinzia Antognelli, and Tatiana Armeni. Glyoxalase 2: towards a broader view of the second player of the glyoxalase system. Antioxidants, 11(11):2131, October 2022. URL: http://dx.doi.org/10.3390/antiox11112131, doi:10.3390/antiox11112131. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/antiox11112131)

[5. (Ahmad2020CDH6) Shahzad Ahmad, Marta del Campo Milan, Oskar Hansson, Ayse Demirkan, Ruiz Agustin, Maria E. Sáez, Nikolaos Giagtzoglou, Alfredo Cabrera-Socorro, Margot H. M. Bakker, Alfredo Ramirez, Thomas Hankemeier, Erik Stomrud, Niklas Mattsson-Carlgren, Philip Scheltens, Wiesje M. van der Flier, M. Arfan Ikram, Anders Malarstig, Charlotte E. Teunissen, Najaf Amin, and Cornelia M. van Duijn. Cdh6 and hagh protein levels in plasma associate with alzheimer’s disease in apoe ε4 carriers. Scientific Reports, May 2020. URL: http://dx.doi.org/10.1038/s41598-020-65038-5, doi:10.1038/s41598-020-65038-5. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-020-65038-5)